Skip to content

Scientific advisory board

Prof. Dr. rer. nat. Ralf Dittrich

image Prof. Dr. rer. nat. Ralf Dittrich
Information
  • Member of the scientific advisory board
  • Born in 1961
  • Study of biology at the Friedrich-Alexander University Erlangen-Nuremberg
  • Holder of the professorship for exp. Reproductive Medicine at the Gynecological Clinic of the University Hospital Erlangen
  • Senior Embryologist (ESHRE)
  • Member of the Advisory Board Reproductive Biology and Medicine of the German Society for Endocrinology
  • Head of IVF and Endocrinology Laboratory at the University Hospital Erlangen, Women’s Hospital
  • Scientific focus:
    Fertility preservation in cancer; cryopreservation of sperm, oocytes, testicular tissue and ovarian tissue; treatment options for premature menopause.

Dr. med. Katharina Egger-Heidrich

image Dr. med. Katharina Egger-Heidrich
Information
  • Member of the Scientific Advisory Board
  • Born in 1987
  • 2008-2014 Studied human medicine at the Medical University of Graz, Austria, and at the University of Salamanca, Spain
  • Specialist in internal medicine, hematology, and oncology at Dresden University Hospital, focusing on follow-up care after cellular therapies,
  • care for graft-versus-host disease, and long-term follow-up care after hematological neoplasms
  • Since 2020, development of interdisciplinary long-term follow-up care (transitional outpatient clinic) in collaboration with pediatric oncology
  • Co-project manager of the interdisciplinary AYA-Start project

Prof. Dr. med. Thorsten Langer

image Prof. Dr. med. Thorsten Langer
Information
  • Member of the scientific advisory board
  • Specialist for pediatric and adolescent medicine
  • 1988-1994 Study of human medicine at the Justus-Liebig-University Gießen
  • 1994-2006 Scientific assistant at the University Hospital Erlangen, Friedrich-Alexander-University, Pediatric and Adolescent Clinic
  • 2004 Acquisition of the specialist qualification “Pediatric and Adolescent Medicine
  • 2005 Acquisition of the teaching qualification and appointment as private lecturer with the habilitation thesis “Late effects of antineoplastic therapies in childhood and adolescence”.
  • 2007 – 2013 Senior physician at the University Hospital Erlangen, Friedrich-Alexander-University, Pediatric and Adolescent Clinic
  • since August 2013 Senior Physician in Pediatric Hematology and Oncology, Clinic for Pediatric and Adolescent Medicine, UKSH Campus Lübeck
  • 2015 Acquisition of the specialist title “Neonatology”
  • Since 2015 W2 professorship “Health care research in pediatric oncology”, University of Lübeck
  • 2018 – present Transfusion Officer Physician at the Clinic for Pediatric and Adolescent Medicine at UKSH Lübeck.
  • Scientific focus:
    Childhood Cancer Survivorship Program
    Therapy-associated secondary diseases and late effects after oncological treatment in childhood – genetic causes of late effects
    Development of national and international follow-up recommendations
    Health care research in the network of nationwide aftercare centers

Prof. Dr. med. Oliver Rick

image Prof. Dr. med. Oliver Rick
Information

Professional career:

  • October 1, 1989–March 22, 1996 Studied human medicine at the Free University of Berlin
  • November 11, 1997 Doctorate (magna cum laude) in human medicine from the Free University of Berlin
  • August 15, 1996 to June 30, 2001 Intern and research assistant in the Department of Internal Medicine with a focus on hematology and oncology (Head: Prof. Dr. D. Huhn), Charité Campus Virchow-Klinikum.
  • July 1, 2001 to April 30, 2002: Research assistant and, from May 1, 2002 to January 14, 2005, scientific assistant at the Medical Clinic II with a focus on oncology and hematology (Head: Prof. Dr. K. Possinger) at Charité Campus Mitte.
  • May 23, 2003 Specialist in internal medicine
  • February 25, 2004 Completion of habilitation procedure, appointment as private lecturer and granting of teaching license and teaching qualification at Charité, University Hospital of Humboldt University in Berlin
  • December 1, 2004 Designation of hematology and internal oncology as areas of specialization
  • Since January 15, 2005 Chief physician at the Reinhardshöhe Clinic, a specialist clinic for oncological rehabilitation in Bad Wildungen-Reinhardshausen
  • October 26, 2005 Reappointment to the Department of Medicine at Philipps University of Marburg
  • September 2, 2008 Appointed adjunct professor of internal medicine at Philipps University of Marburg
  • Since July 1, 2025 Medical Director of MVZ für Hämatologie und Onkologie Waldeck-Frankenberg GmbH

Memberships:

American Society of Clinical Oncology (ASCO), European Society for Medical Oncology (ESMO), Deutsche Gesellschaft für Hämatologie und Onkologie (DGHO), Deutsche Krebsgesellschaft (DKG), Hessische Krebsgesellschaft (HKG), Arbeitsgemeinschaft Onkologische Rehabilitation und Sozialmedizin der Deutschen Krebsgesellschaft (AGORS), Arbeitsgemeinschaft Internistische Onkologie der Deutschen Krebsgesellschaft (AIO), Deutsche Gesellschaft für Rehabilitationswissenschaften (DGRW)

Prof. Dr. Joachim Wiskemann

image Prof. Dr. Joachim Wiskemann
Information
  • Member of the scientific advisory board
  • Sports scientist and sports psychologist
  • 2000-2005 Studies at the Ruprecht-Karls-University of Heidelberg
  • 2010 Doctorate in sports science (summa cum laude)
  • 2017 Award of the Venia Legendi for the subject sports science
  • Head of the working group “Oncological Sport and Exercise Therapy” at the National Center for Tumor Diseases (NCT) and the University Hospital in Heidelberg
  • Adjunct Assistant Professor of Public Health Science at Penn State University, PA (USA)
  • Management of an exercise therapy program for oncology patients with more than 10,000 therapy participants annually
  • Publication of more than 100 nationally and internationally renowned scientific papers
  • Science Award 2017/2018 in Gold of the German Olympic Sports Confederation (DOSB) for his postdoctoral thesis “Motor Performance as a Central Parameter in Oncology”.
  • 2011 Foundation of the network OnkoAktiv
  • Spokesperson and founder of the “National Expert Group on Exercise Therapy and Physical Activity in Oncology (NEBKO)” established in 2015 in the German Cancer Society (AGSMO)
  • Fellow of the European (ECSS) and American Association for Sport Science (ACSM).
  • Scientific focus:
    Personalization of sports and physical activity therapy in cancer patients.

Photo: © NCT/P.Benjamin

PD Dr. med. Rachel Würstlein

image PD Dr. med. Rachel Würstlein
Information
  • Member of the scientific advisory board
  • Born in 1971
  • Specialist in gynecology and obstetrics
  • Studies at the University of Munich and Caen, France
  • Active member of the WSG study group
  • Head of the Department of Breast Cancer and Gynecological Oncology at the Center for Precision Medicine, LMU Klinikum
  • Advisory board member CCC Munich LMU
  • Member AG Outreach of the DKG / Network CCC
  • Advisory Board Breast Cancer Germany e. V.
  • Advisory member ABC Global Alliance
  • DKG: AG Women in Oncology
  • ESO- Lecture: Certificate of Competence in Breast Cancer
  • Additional training: Medicinal Tumor Therapy, Palliative Medicine, Specialized Genetic Training, Psychosomatics, DEGUM II Mammasonography, Hospital Management, Specialist Auditor.
  • Scientific focus:
    Translational research early and late breast carcinoma
    Special groups on breast carcinoma: men, pregnancy, young patients
    Health care research with focus on oral tumor therapy and interprofessional oncology and lifestyle